EUROIMMUN US exhibited at the American Society of Nephrology (ASN) Kidney Week 2014, the premier international nephrology meeting, in Philadelphia November 11th-16th. More than 13,000 professionals participated and the EUROIMMUN attendees reported on valuable feedback regarding anti-PLA2R antibodies, the new biomarker of primary membranous nephropathy. “ASN went very well”, concluded Todd Walbrun, the National Accounts […]
There are diseases whose pathogenesis has been known for decades. The actual cause, however, remains a secret despite intensive research. For decades, it has been known that deposits of immune complexes are formed along the basal membrane of the glomerulus in membranous nephropathy (previously known as membranous glomerulonephritits), causing tissue inflammation and impairment of kidney filtration. But the antigen which is targeted by
The MEDICA is considered as leading international medical trade fair for suppliers’ products in medical manufacture. EUROIMMUN presented again with a large booth together with 4,830 other exhibitors in 2014. The conclusion of the organizers is positive: they expect that the 130,000 visitors from about 120 different countries will generate tailwinds for the future export business. And what will
The discovery of autoantibodies against the phospholipase A2 receptor 1 (PLA2R) is considered a milestone in nephrology research. They are the first described serological marker for primary membranous nephropathy. Their value in membranous nephropathy diagnostics is the subject of many recent publications. Primary and secondary membranous nephropathy: differential diagnosis essential Membranous nephropathy is the major cause of nephrotic syndrome in
Iswariya is from India. She came to Germany to earn her “Scientist-hood”, as she calls it. Now, she is a PhD student in a EUROIMMUN laboratory. Maybe you can tell us why you came to Germany and to EUROIMMUN? Well, in a country like India, women often are expected to put the needs of their family
